Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is This Pharma Stock a Buy?


Shares of Eli Lilly (NYSE: LLY) are up nearly 55% year to date, which raises the following questions: Have investors missed the boat on the stock? Or is now still a good time to buy?

Let's look at Eli Lilly's third-quarter operating results, which were reported on Oct. 26, its solvency, and the stock's current valuation to address these questions.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
LLY
Share

Comments